Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis

Rheumatology International

Volumn 31, Issue 8, 2011, Pages 1051-1054

  Ostojic, Predrag ^a   Damjanov, Nemanja ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Alpha tocopherol; Ascorbic acid; Systemic sclerosis

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CARBON MONOXIDE; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE; DNA TOPOISOMERASE I ANTIBODY; METOCLOPRAMIDE; NIFEDIPINE; PREDNISOLONE; PROTEIN ANTIBODY; RANITIDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MALE; MODIFIED RODNAN SKIN SCORE; PRIORITY JOURNAL; SCORING SYSTEM; SKIN DISEASE; SYSTEMIC SCLEROSIS; THERAPY EFFECT;

ALPHA-TOCOPHEROL; ANTIOXIDANTS; ASCORBIC ACID; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; LUNG; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; SCLERODERMA, DIFFUSE; SKIN;

EID: 79961169894     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1398-1     Document Type: Article

References (17)

1. AL Herrick M Matucci 2001 The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis Clin Exp Rheumatol 19 4 8 11247323 1:STN:280:DC%2BD3MzmvVajuw%3D%3D (Pubitemid 32203838)
2. DR Blake P Winyard DGI Scott, et al. 1985 Endothelial cytotoxicity in inflammatory vascular diseases-the possible role of oxidized lipoproteins Ann Rheum Dis 44 176 182 3977420 10.1136/ard.44.3.176 1:CAS:528:DyaL2MXitVajurc%3D (Pubitemid 15123912)
3. KR Bruckdorfer JB Hillary T Bunce, et al. 1994 Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis Arthritis Rheum 38 1060 1067 10.1002/art.1780380807
4. T Yamamoto I Katayama K Nichioka 1998 Nitric oxide production and inducible nitric oxide synthetase expression in systemic sclerosis J Rheumatol 25 314 317 9489825 1:STN:280:DyaK1c7kvFCluw%3D%3D (Pubitemid 28088261)
5. SA Cotton AL Herrick MIV Joyson, et al. 1999 Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin J Pathol 189 273 278 10547586 10.1002/(SICI)1096-9896(199910)189:2<273::AID-PATH413>3. 0.CO;2-4 1:CAS:528:DyaK1MXms12mtbY%3D (Pubitemid 29448924)
6. T Yamamoto Y Eawada I Katayama, et al. 1998 Increased production of nitric oxide stimulated by interleukin-1b in peripheral blood mononuclear cells in patients with systemic sclerosis Br J Rheumatol 37 1123 1125 9825753 10.1093/rheumatology/37.10.1123 1:STN:280:DyaK1M%2FktFWjsg%3D%3D
7. G Cavallo L Sabadini L Rollo, et al. 1999 Nitric oxide synthesis in peripheral blood mononuclear and polymorphonuclear cells from patients with systemic sclerosis Rheumatology 38 1301 1304 10587569 10.1093/rheumatology/38. 12.1301-a 1:STN:280:DC%2BD3c%2Fls1Cnsw%3D%3D
8. AC Lundberg, et al. 1992 Dietary intake and nutritional status in patients with systemic sclerosis Ann Rheum Dis 51 10 1143 1148 1332633 10.1136/ard.51.10.1143 1:STN:280:DyaK3s%2FnsVWltA%3D%3D
9. AL Herrick H Worthington F Rieley, et al. 1996 Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis J Rheumatol 23 650 653 8730121 1:STN:280:DyaK283otVWlsQ%3D%3D (Pubitemid 26135136)
10. LS Teh CW Johns JL Shaffer, et al. 1997 Ascorbic acid and absorption in patients with systemic sclerosis J Rheumatol 24 2353 2357 9415641 1:CAS:528:DyaK2sXnvFOitbk%3D (Pubitemid 28005135)
11. V Steen T Medsger 2000 Severe organ involvement in patients with diffuse scleroderma Arthritis Rheum 43 2437 2444 11083266 10.1002/1529-0131(200011)43: 11<2437::AID-ANR10>3.0.CO;2-U 1:STN:280:DC%2BD3M%2FktFequw%3D%3D
12. CP Denton TD Bunce MB Dorado, et al. 1999 Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon Rheumatology 38 309 315 10378706 10.1093/rheumatology/38.4.309 1:CAS:528:DyaK1MXjslOmtrg%3D (Pubitemid 29507178)
13. AL Herrick S Hollis D Schofield, et al. 2000 A double-blind, placebo controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis Clin Exp Rheumatol 18 349 356 10895372 1:STN:280:DC%2BD3M%2FitVGjsg%3D%3D (Pubitemid 30409104)
14. E Herrera C Barbas 2001 Vitamin E: action, metabolism and perspectives J Physiol Biochem 57 2 43 56 10.1007/BF03179812 1:CAS:528:DC%2BD3MXnt1Wgsb8%3D
15. L Packer SU Weber G Rimbach 2001 Molecular aspects of alpha-tocotrienol antioxidant action and cell signaling J Nutr 131 2 369 373
16. L Cominacini U Garbin AF Pasini, et al. 1997 Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells Free Radic Biol Med 22 1-2 117 127 8958136 10.1016/S0891-5849(96)00271-7 1:CAS:528:DyaK28XnsVGjtbg%3D
17. AC Chan M Wagner C Kennedy, et al. 1998 Vitamin E upregulates arachidonic acid release and phospholipase A2 in megakaryocytes Mol Cell Biochem 189 1-2 153 159 9879666 10.1023/A:1006954015678 1:CAS:528:DyaK1MXktFWjsA%3D%3D (Pubitemid 28556560)